Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

A roundup of regulatory activity around the country
Winter 2020/2021

By the Numbers

A collection of workers’ compensation facts and figures
Winter 2020/2021

Rising to the Challenge: Meeting Adversity During Complex Times

A message from our Chief Executive Officer
Spring/Summer 2020

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

WCRI Reports on Changes in the Medical Workforce and the Impact on Claims

Pandemic driven increases to provider vacancies have increased reliance on nurse practitioners and physician assistants.
Feb 2025

A Hot Topic: The Latest News on Workers and Extreme Heat

Recent data insights, state proposals, and updates on federal rulemaking procedures.
Feb 2025

FDA Approves Generic GLP-1 Victoza Injections for Type 2 Diabetes

Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.
Jan 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.
Nov 2018

CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.
Sep 2018

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.
Aug 2018
1 … 24 25 26 27 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle